Karin Karlsson
Overview
Explore the profile of Karin Karlsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1027
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharman J, Egyed M, Jurczak W, Skarbnik A, Pagel J, Flinn I, et al.
Leukemia
. 2024 Dec;
39(2):529.
PMID: 39627506
No abstract available.
2.
Karlsson K, Radholm K, Dunford E, Wu J, Neal B, Sundstrom J
Front Public Health
. 2023 Jun;
11:1182132.
PMID: 37361177
Background: Dietary sodium has a dose-response relationship with cardiovascular disease, and sodium intake in Sweden exceeds national and international recommendations. Two thirds of dietary sodium intake comes from processed foods,...
3.
Sharman J, Egyed M, Jurczak W, Skarbnik A, Pagel J, Flinn I, et al.
Leukemia
. 2022 Jan;
36(4):1171-1175.
PMID: 34974526
No abstract available.
4.
McCrae C, Olsson M, Gustafson P, Malmgren A, Aurell M, Fageras M, et al.
Clin Exp Allergy
. 2020 Oct;
51(2):273-283.
PMID: 33091192
Background: Upper respiratory tract infections (URTIs) are important triggers for asthma exacerbations. We hypothesized that inhalation of the anti-viral cytokine, interferon (IFN)-β, during URTI, could prevent these exacerbations. Objective: To...
5.
Sharman J, Egyed M, Jurczak W, Skarbnik A, Pagel J, Flinn I, et al.
Lancet
. 2020 Apr;
395(10232):1278-1291.
PMID: 32305093
Background: Acalabrutinib is a selective, covalent Bruton tyrosine-kinase inhibitor with activity in chronic lymphocytic leukaemia. We compare the efficacy of acalabrutinib with or without obinutuzumab against chlorambucil with obinutuzumab in...
6.
Bergfelt Lennmyr E, Karlsson K, Abrahamsson M, Ebrahim F, Lubking A, Hoglund M, et al.
Eur J Haematol
. 2020 Feb;
104(6):571-580.
PMID: 32080889
Objectives: The use of patient-reported outcome (PRO) measured outside clinical trials is not well defined. We report the first analysis of the prospective PRO study within the Swedish acute myeloid...
7.
Vuckovic V, Karlsson K, Sunnqvist C
Nurse Educ Pract
. 2019 Nov;
41:102627.
PMID: 31751904
Objective: The aim of this study was to investigate preceptors' and nursing students' experiences of peer learning in a psychiatric context during their clinical education. Design: A qualitative research design...
8.
Lennmyr E, Karlsson K, Ahlberg L, Garelius H, Hulegardh E, Izarra A, et al.
Eur J Haematol
. 2019 May;
103(2):88-98.
PMID: 31074910
Objectives: As new, effective therapies emerge for acute lymphoblastic leukaemia (ALL), the results of clinical trials need to relate to standard of care. Methods: We used the population-based Swedish ALL...
9.
Winqvist M, Andersson P, Asklid A, Karlsson K, Karlsson C, Lauri B, et al.
Haematologica
. 2018 Dec;
104(5):e208-e210.
PMID: 30514799
No abstract available.
10.
Eketorp Sylvan S, Asklid A, Johansson H, Klintman J, Bjellvi J, Tolvgard S, et al.
Haematologica
. 2018 Nov;
104(4):797-804.
PMID: 30467205
The aim of this study was to investigate long-term outcome following first-line therapy in consecutive chronic lymphocytic leukemia (CLL) patients in a well-defined geographic area: Sweden. All patients diagnosed with...